Efficiency of laser-assisted intracytoplasmic sperm injection in a human assisted reproductive techniques program
- PMID: 22384434
- PMCID: PMC3283067
- DOI: 10.5653/cerm.2011.38.3.148
Efficiency of laser-assisted intracytoplasmic sperm injection in a human assisted reproductive techniques program
Abstract
Objective: Laser-assisted intracytoplasmic sperm injection (LA-ICSI), also known as micro-opening or thinning of the zona pellucida (ZP) prior to ICSI, may help to reduce mechanical damage to the oocyte during the procedure. The aim of the present study was to evaluate and analyze the efficacy of our institutional LA-ICSI program, which features laser-assisted ZP thinning prior to ICSI, in comparison with conventional ICSI (C-ICSI), performed on patients with different clinical characteristics.
Methods: Patients undergoing a total of 212 ICSI cycles were randomly divided into an LA-ICSI group (106 cycles) and a conventional ICSI group (106 cycles). To reduce tissue damage, we thinned the ZP by approximately 70%, using a laser, before ICSI. Patients thus treated formed the LA-ICSI group. Comparisons included the morphological quality of transferred embryos, blastocyst development of the remaining embryos, and clinical pregnancy, in terms of ICSI method and patient characteristics.
Results: Fertilization, development of remaining embryos, and pregnancy rate were significantly higher in the LA-ICSI group compared with the C-ICSI group. Fertilization, embryonic development, and the pregnancy rate were all improved in younger patients (<38 years of age) and in those who underwent a low number of IVF-ET attempts (<3 trials). In addition, the pregnancy rate was increased in older patients.
Conclusion: LA-ICSI may be useful in improving the chance of pregnancy in all ICSI patients.
Keywords: Clinical Outcome; Human; In Vitro Fertilization-embryo Transfer; Intracytoplasmic Sperm Injection; Laser-assisted Intracytoplasmic Sperm Injection; Zona Pellucida Thinning.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
Similar articles
-
The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.Hum Reprod. 2017 Jan;32(1):119-124. doi: 10.1093/humrep/dew298. Epub 2016 Nov 16. Hum Reprod. 2017. PMID: 27852688
-
Laser-assisted zona pellucida thinning prior to routine ICSI.Hum Reprod. 2004 Mar;19(3):573-8. doi: 10.1093/humrep/deh093. Epub 2004 Jan 29. Hum Reprod. 2004. PMID: 14998954 Clinical Trial.
-
Outcomes of intracytoplasmic sperm injection using the zona pellucida-bound sperm or manually selected sperm.J Assist Reprod Genet. 2016 May;33(5):597-601. doi: 10.1007/s10815-016-0676-6. Epub 2016 Mar 3. J Assist Reprod Genet. 2016. PMID: 26941098 Free PMC article. Clinical Trial.
-
Guidelines for the number of embryos to transfer following in vitro fertilization No. 182, September 2006.Int J Gynaecol Obstet. 2008 Aug;102(2):203-16. doi: 10.1016/j.ijgo.2008.01.007. Int J Gynaecol Obstet. 2008. PMID: 18773532 Review.
-
Intra-cytoplasmic sperm injection versus partial zona dissection, subzonal insemination and conventional techniques for oocyte insemination during in vitro fertilisation.Cochrane Database Syst Rev. 2000;(2):CD001301. doi: 10.1002/14651858.CD001301. Cochrane Database Syst Rev. 2000. PMID: 10796764 Updated. Review.
Cited by
-
From Zygote to Blastocyst: Application of Ultrashort Lasers in the Field of Assisted Reproduction and Developmental Biology.Diagnostics (Basel). 2021 Oct 14;11(10):1897. doi: 10.3390/diagnostics11101897. Diagnostics (Basel). 2021. PMID: 34679594 Free PMC article. Review.
-
Oocyte Degeneration After ICSI Is Not an Indicator of Live Birth in Young Women.Front Endocrinol (Lausanne). 2021 Aug 16;12:705733. doi: 10.3389/fendo.2021.705733. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34484119 Free PMC article.
-
Controlled hatching at the prescribed site using femtosecond laser for zona pellucida drilling at the early blastocyst stage.J Assist Reprod Genet. 2021 Feb;38(2):517-529. doi: 10.1007/s10815-020-01998-x. Epub 2020 Nov 17. J Assist Reprod Genet. 2021. PMID: 33205358 Free PMC article.
-
Thoughts on the popularity of ICSI.J Assist Reprod Genet. 2021 Jan;38(1):101-123. doi: 10.1007/s10815-020-01987-0. Epub 2020 Nov 6. J Assist Reprod Genet. 2021. PMID: 33155089 Free PMC article. Review.
-
The effect of ICSI in infertility couples with non-male factor: a systematic review and meta-analysis.J Assist Reprod Genet. 2020 Dec;37(12):2929-2945. doi: 10.1007/s10815-020-01970-9. Epub 2020 Oct 19. J Assist Reprod Genet. 2020. PMID: 33073301 Free PMC article.
References
-
- Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet. 1992;340:17–18. - PubMed
-
- Ebner T, Moser M, Sommergruber M, Jesacher K, Tews G. Complete oocyte activation failure after ICSI can be overcome by a modified injection technique. Hum Reprod. 2004;19:1837–1841. - PubMed
-
- Ola B, Afnan M, Sharif K, Papaioannou S, Hammadieh N, Barratt CL. Should ICSI be the treatment of choice for all cases of in-vitro conception? Considerations of fertilization and embryo development, cost effectiveness and safety. Hum Reprod. 2001;16:2485–2490. - PubMed
-
- Oehninger S, Gosden RG. Should ICSI be the treatment of choice for all cases of in-vitro conception? No, not in light of the scientific data. Hum Reprod. 2002;17:2237–2242. - PubMed
-
- Bhattacharya S, Hamilton MP, Shaaban M, Khalaf Y, Seddler M, Ghobara T, et al. Conventional in-vitro fertilisation versus intracytoplasmic sperm injection for the treatment of non-male-factor infertility: a randomised controlled trial. Lancet. 2001;357:2075–2079. - PubMed
LinkOut - more resources
Full Text Sources
